Skip to main content

124153 -

The article details recent breakthroughs in "linker" technology and more effective payloads that have led to a surge in FDA-approved treatments for breast, lung, and blood cancers.

A 2026 study in Life Sciences (Article 124153 ) examines how specific viruses can suppress oral cancer by inducing a form of cell death known as ferroptosis .

Researchers are now focusing on overcoming drug resistance and expanding ADCs beyond oncology to treat autoimmune and infectious diseases. 2. Political Science: Trust in European Institutions 124153

The study finds that trust is not isolated; when a citizen loses faith in their national parliament, that distrust often "spills over" to the European Commission and the European Parliament.

Early challenges included drug instability and low potency, leading to many failed clinical trials in the late 20th century. Antibody–Drug Conjugates: The Past

Antibody–Drug Conjugates: The Past, Present and Future Source: Annual Review of Cancer Biology (DOI: 10.1146/annurev-cancerbio-070824-124153)

The relationship is often asymmetric . Negative events (like economic crises) have a much stronger impact on decreasing trust than positive events have on increasing it. 124153

ADCs combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, allowing them to kill cancer cells while sparing healthy tissue.